- Home
- SCYX vs GREE Comparison
SCYX vs GREE Comparison
Compare SCYX & GREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- GREE
- Stock Information
- Founded
- SCYX 1999
- GREE 1937
- Country
- SCYX United States
- GREE United States
- Employees
- SCYX N/A
- GREE N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- GREE Investment Bankers/Brokers/Service
- Sector
- SCYX Health Care
- GREE Finance
- Exchange
- SCYX Nasdaq
- GREE Nasdaq
- Market Cap
- SCYX 26.6M
- GREE 21.5M
- IPO Year
- SCYX 2014
- GREE N/A
- Fundamental
- Price
- SCYX $0.88
- GREE $1.35
- Analyst Decision
- SCYX
- GREE
- Analyst Count
- SCYX 0
- GREE 0
- Target Price
- SCYX N/A
- GREE N/A
- AVG Volume (30 Days)
- SCYX 212.7K
- GREE 191.5K
- Earning Date
- SCYX 08-19-2025
- GREE 08-18-2025
- Dividend Yield
- SCYX N/A
- GREE N/A
- EPS Growth
- SCYX N/A
- GREE N/A
- EPS
- SCYX N/A
- GREE N/A
- Revenue
- SCYX $2,630,000.00
- GREE $59,442,000.00
- Revenue This Year
- SCYX $410.22
- GREE N/A
- Revenue Next Year
- SCYX $248.83
- GREE N/A
- P/E Ratio
- SCYX N/A
- GREE N/A
- Revenue Growth
- SCYX N/A
- GREE N/A
- 52 Week Low
- SCYX $0.66
- GREE $0.58
- 52 Week High
- SCYX $1.82
- GREE $3.84
- Technical
- Relative Strength Index (RSI)
- SCYX 68.89
- GREE 36.87
- Support Level
- SCYX $0.68
- GREE $1.45
- Resistance Level
- SCYX $0.92
- GREE $1.63
- Average True Range (ATR)
- SCYX 0.04
- GREE 0.15
- MACD
- SCYX 0.02
- GREE -0.04
- Stochastic Oscillator
- SCYX 83.33
- GREE 1.45
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About GREE Greenidge Generation Holdings Inc.
Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. Company operates in three segments: Crypto Mining, Datacenter Hosting, Power and Capacity. The company owns and operates facilities at two locations: the Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.